BF Biosciences posts strong Q1 profit

October 27, 2025 (MLN): BF Biosciences Limited (PSX: BFBIO) has reported a significant surge in profitability for the first quarter ended September 30, 2025, driven by robust top-line growth and improved gross efficiency, despite a tighter net margin.

The company’s Profit after taxation jumped to Rs159.52 million in Q1 2025, a substantial increase of 38.39% compared to the Rs115.27m reported in the same period last year.

However, earnings per share saw a marginal decline to Rs 1.81 from Rs 1.82, possibly due to a slightly higher weighted average number of shares outstanding.

The growth in bottom line was marked by a key improvement in the company's manufacturing efficiency, with the Gross Profit Margin increasing by 2.02 percentage points to 42.69% from 40.67% last year.

This indicates that a larger share of every rupee in revenue is being retained after accounting for the cost of goods sold.

However, the aggressive scaling of operations pushed up overheads, causing the Net Profit Margin to contract.

The net margin fell by 1.75 percentage points to 6.56% in the current period, down from 8.31% last year, reflecting the sharp rise in operating expenses and income tax.

Revenue led the performance as it jumped over 75% to Rs2.43 billion from Rs1.39bn in the corresponding quarter of 2024.

This significant sales growth led to a robust increase in Gross profit, which climbed by 84.15% to Rs1.04bn.

The increase in profitability was achieved despite Selling and distribution expenses rising sharply by 132.62% to Rs709.17m, and Administrative expenses increasing by 234.45% to Rs39.85m.

This expansion in overheads suggests an aggressive investment in scaling the sales network and corporate infrastructure.

Positive contributions came from a 24.67% reduction in Finance cost (to Rs26.39m) and a 1351.04% surge in Other income (to Rs34.85m).

Finally, the Profit before income tax increased by 47.55% to Rs267.89m.

However, a higher Income tax expense, which rose by 63.41% to Rs108.37m, curtailed the final profit growth.

Copyright Mettis Link News